Article

Clinical validation of a next-generation sequencing assay for 17 cancer related mutations in non-small cell Lung cancer

2023-05-02

Abstract excerpt

<h4>Background: </h4> Circulating tumor DNA (ctDNA) enables rapid and repeat testing of actionable mutations with fewer side effects compared to tissue biopsy. And the use of next-generation sequencing (NGS) based on ctDNA as a diagnostic tool in clinical settings is growing. We developed a hybridization capture massively parallel NGS assay using ctDNA, USCI-CT, across 20 cancer relevant genes of non-small cell lu...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 2198b957-4e5e-5c8b-a258-b1ea64da8044
DOI: 10.21203/rs.3.rs-2740545/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Clinical validation of a next-generation sequencing assay for 17 cancer related mutations in non-small cell Lung cancerDOI 10.21203/rs.3.rs-2740545/v1Read

Genomic Profiling of NGS-based ctDNA from Chinese Non-Small Cell Lung Cancer PatientsSemantic proximity Read

Implementation of Next Generation Sequencing-Based Liquid Biopsy for Clinical Molecular Diagnostics in Non-Small Cell Lung Cancer (NSCLC) PatientsSemantic proximity Read

Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in Non-Small Cell Lung Cancer.Semantic proximity Read

Genomic profiling of NGS-based ctDNA from Chinese non-small cell lung cancer patients.Semantic proximity Read

Circulating Tumor DNA Mutation Profiling by Targeted Next Generation Sequencing Provides Guidance for Personalized Treatments in Multiple Cancer Types.Semantic proximity Read

The Early Diagnosis in Lung Cancer by the Detection of Circulating Tumor DNASemantic proximity Read

Real-world application of targeted next-generation sequencing for identifying molecular variants in Asian non-small-cell lung cancerSemantic proximity Read

Strategies for improving detection of circulating tumor DNA using next generation sequencing.Semantic proximity Read

Implementing liquid biopsy NGS in stage III/IV NSCLC: clinical utility assessment from a real-world Chinese cohort.Semantic proximity Read

Clinical utility of analyzing circulating tumor DNA in patients with non-small cell lung carcinomaSemantic proximity Read

The Landscape of Actionable Genomic Alterations by Next-Generation Sequencing in Tumor Tissue Versus Circulating Tumor DNA in Chinese Patients With Non-Small Cell Lung CancerSemantic proximity Read

Genomic Landscape of Non-Small Cell Lung Cancer (NSCLC) in East Asia Using Circulating Tumor DNA (ctDNA) in Clinical Practice.Semantic proximity Read